NEW YORK, Feb. 6 (GenomeWeb News) - OGT Services announced today that Oxford Genetics Knowledge Park is using its custom-made microarrays to develop tests for use in NHS Regional Genetics Laboratories.

 

The microarrays will be used to develop tests for complex diseases such as colorectal cancer, cardiovascular diseases, and learning disabilities, said OGT.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.